Resistance to activated protein C is a risk factor for fibrostenosis in Crohn’s disease

doi:10.3748/wjg.v12.i37.6026

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 37

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2662)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-2) series.

Item

Count

PDF

308

HTML

2051

Figures (1-1)

156

Tables (1-2)

147

Sum=2662

Oct 7, 2006 (publication date) through May 4, 2024

Times Cited of This Article

Times Cited (3)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Oct 7, 2006; 12(37): 6026-6031
Published online Oct 7, 2006. doi: 10.3748/wjg.v12.i37.6026

Open in New Tab Full Size Figure Download Figure

Figure 1 Kaplan-Meier curves for CD patients with and without aPCR, for remaining free of intestinal CD-related operation with fibrostenosis. A significantly lower proportion of patients with aPCR remained free of operation with fibrostenosis as compared to CD patients without aPCR (P = 0.0216; exact log-rank test). The calculation was limited to a period of 120 mo.

Citation: Novacek G, Miehsler W, Palkovits J, Reinisch W, Waldhör T, Kapiotis S, Gangl A, Vogelsang H. Resistance to activated protein C is a risk factor for fibrostenosis in Crohn’s disease. World J Gastroenterol 2006; 12(37): 6026-6031
URL: https://www.wjgnet.com/1007-9327/full/v12/i37/6026.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i37.6026